staurosporine has been researched along with Cardiovascular Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hartmann, RW; Hu, Q; Yin, L | 1 |
Abdel-Wahab, O; Barbui, T; Cortes, JE; Gale, RP; Gotlib, J; Hehlmann, R; Khoury, HJ; Koschmieder, S; Mauro, M; Mesa, R; Mughal, TI; Radich, JP; Saglio, G; Saussele, S; Van Etten, RA; Verstovek, S | 1 |
Blunt, M; Craggs, P; Hardwick, P; Hobbs, CI; Rowland, P; Shillings, A; Singh, O; Skarzynski, T; Smith, KJ; Tanner, R; Wall, I; Witty, DR | 1 |
Bourikas, D; Kaloyianni, M; Koliakos, G | 1 |
1 review(s) available for staurosporine and Cardiovascular Diseases
Article | Year |
---|---|
Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms.
Topics: Antineoplastic Agents; Calreticulin; Cardiovascular Diseases; Cell Transformation, Neoplastic; Chronic Disease; Congresses as Topic; Epigenesis, Genetic; Fusion Proteins, bcr-abl; Humans; Janus Kinase 2; Mastocytosis, Systemic; Mutation; Myeloproliferative Disorders; Protein Kinase Inhibitors; Remission Induction; Staurosporine; Translational Research, Biomedical | 2018 |
3 other study(ies) available for staurosporine and Cardiovascular Diseases
Article | Year |
---|---|
Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases.
Topics: Aldosterone; Animals; Benzimidazoles; Cardiovascular Diseases; Cytochrome P-450 CYP11B2; Fadrozole; Humans; Indans; Indoles; Kidney Diseases; Mineralocorticoids; Naphthalenes; Quinolines; Receptors, Mineralocorticoid | 2014 |
Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug design.
Topics: Binding Sites; Cardiovascular Diseases; Crystallography, X-Ray; Drug Design; Humans; Ligands; MAP Kinase Kinase Kinase 5; Neoplasms; Neurodegenerative Diseases; Sf9 Cells; Signal Transduction; Staurosporine | 2013 |
The effect of insulin on Na+-H+ antiport activity of obese and normal subjects erythrocytes.
Topics: Adult; Amiloride; Cardiovascular Diseases; Enzyme Inhibitors; Erythrocytes; Female; Humans; Hydrogen-Ion Concentration; Hyperinsulinism; Insulin; Insulin Resistance; Ion Transport; Kinetics; Male; Middle Aged; Obesity; Protein Kinase C; Sodium; Sodium-Hydrogen Exchangers; Staurosporine | 2001 |